Photo from wikipedia
Systemic thrombolysis with rt-PA is contraindicated in patients with acute ischemic stroke anticoagulated with dabigatran. This expert opinion provides guidance on the use of the specific reversal agent idarucizumab followed… Click to show full abstract
Systemic thrombolysis with rt-PA is contraindicated in patients with acute ischemic stroke anticoagulated with dabigatran. This expert opinion provides guidance on the use of the specific reversal agent idarucizumab followed by rt-PA and/or thrombectomy in patients with ischemic stroke pre-treated with dabigatran. The use of idarucizumab followed by rt-PA is covered by the label of both drugs.
Keywords:
ischemic stroke;
thrombectomy patients;
treated dabigatran;
expert opinion;
acute ischemic;
stroke
Journal Title: International Journal of Stroke
Year Published: 2017
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: International Journal of Stroke
Year Published: 2017
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!